NO845278L - Substituerte imidazoler. - Google Patents

Substituerte imidazoler.

Info

Publication number
NO845278L
NO845278L NO845278A NO845278A NO845278L NO 845278 L NO845278 L NO 845278L NO 845278 A NO845278 A NO 845278A NO 845278 A NO845278 A NO 845278A NO 845278 L NO845278 L NO 845278L
Authority
NO
Norway
Prior art keywords
formula
compound
residue
phenyl
methyl
Prior art date
Application number
NO845278A
Other languages
English (en)
Norwegian (no)
Inventor
Armin Zuest
Walter Schilling
Romeo Paioni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO845278L publication Critical patent/NO845278L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO845278A 1983-12-30 1984-12-28 Substituerte imidazoler. NO845278L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH698883 1983-12-30

Publications (1)

Publication Number Publication Date
NO845278L true NO845278L (no) 1985-07-01

Family

ID=4318179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO845278A NO845278L (no) 1983-12-30 1984-12-28 Substituerte imidazoler.

Country Status (15)

Country Link
EP (1) EP0149976A3 (da)
JP (1) JPS60158176A (da)
AU (1) AU569135B2 (da)
CA (1) CA1233828A (da)
DD (1) DD228249A5 (da)
DK (1) DK614384A (da)
ES (6) ES8800166A1 (da)
FI (1) FI845140A7 (da)
GR (1) GR82625B (da)
HU (1) HU193916B (da)
IL (1) IL73955A (da)
NO (1) NO845278L (da)
NZ (1) NZ210722A (da)
PT (1) PT79761B (da)
ZA (1) ZA8410105B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200947B1 (de) 1985-04-26 1990-09-12 F. Hoffmann-La Roche Ag 1,3-Disubstituierte Imidazoliumsalze
JPS62103068A (ja) * 1985-09-23 1987-05-13 ヘキスト・アクチエンゲゼルシヤフト アリ−ルメチルアゾ−ルおよびそれらの塩ならびにそれらの製法
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE3812483A1 (de) * 1987-06-27 1989-01-05 Bayer Ag (azolyl-vinyl)-phenol-alkenylether
JPH03130266A (ja) * 1989-07-28 1991-06-04 Hodogaya Chem Co Ltd 置換フェニルアルキルイミダゾール誘導体
DE3931554A1 (de) * 1989-09-22 1991-04-04 Hoechst Ag (+)-(2-hydroxy-2-adamantyl)-1-imidazolyl-3- tolyl-methan und dessen salze, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−３、５−（トリフルオロメチル）ベンジルアミンの製造方法
DE10032335A1 (de) * 2000-07-04 2002-01-17 Cognis Deutschland Gmbh Dimethylbenzol-Derivate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1487326A (fr) * 1966-01-18 1967-07-07 Clin Byla Ets Dérivés imidazoliques et leur préparation
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2546064A1 (de) * 1975-10-10 1977-04-21 Schering Ag Triazolderivate und verfahren zu ihrer herstellung
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums

Also Published As

Publication number Publication date
FI845140L (fi) 1985-07-01
ES8705224A1 (es) 1987-05-01
ES8705395A1 (es) 1987-05-01
IL73955A0 (en) 1985-03-31
IL73955A (en) 1988-09-30
EP0149976A2 (de) 1985-07-31
HU193916B (en) 1987-12-28
ES539204A0 (es) 1987-10-16
PT79761A (en) 1985-01-01
DK614384D0 (da) 1984-12-20
ES8705397A1 (es) 1987-05-01
ES8705396A1 (es) 1987-05-01
FI845140A0 (fi) 1984-12-27
ES8705394A1 (es) 1987-05-01
CA1233828A (en) 1988-03-08
ZA8410105B (en) 1985-08-28
FI845140A7 (fi) 1985-07-01
DD228249A5 (de) 1985-10-09
AU569135B2 (en) 1988-01-21
ES552558A0 (es) 1987-05-01
NZ210722A (en) 1987-06-30
JPS60158176A (ja) 1985-08-19
ES552559A0 (es) 1987-05-01
PT79761B (en) 1986-12-10
GR82625B (en) 1985-05-07
ES8800166A1 (es) 1987-10-16
DK614384A (da) 1985-07-01
EP0149976A3 (de) 1986-12-10
AU3723584A (en) 1985-07-04
ES552555A0 (es) 1987-05-01
HUT36463A (en) 1985-09-30
ES552556A0 (es) 1987-05-01
ES552557A0 (es) 1987-05-01

Similar Documents

Publication Publication Date Title
US4355040A (en) Hypotensive imidazole-5-acetic acid derivatives
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
RU2284323C2 (ru) Фенилэтенил- или фенилэтенилпроизводные в качестве антагонистов глутаматного рецептора
BE1001004A4 (fr) Nouvelles cetones tricycliques utiles comme medicaments, procede et intermediaires pour leur preparation.
CY1479A (en) 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives
US4814344A (en) Indole derivatives
IL36237A (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
NO162176B (no) Middel for bekjempelse av plantesykdommer og anvendelse derav.
CA1233828A (en) Substituted imidazoles
US5607957A (en) Imidazole, triazole and tetrazole derivatives
US6211219B1 (en) Aminocyclohexane derivatives as 5-HT receptor agonists
US4094987A (en) 2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)-ethanols
NO833663L (no) Furaner
US4064244A (en) Organic compounds
HU192836B (en) Process for producing substituted azabicyclo-alkane derivatives and pharmaceutical compositions containing them
US4634713A (en) Antihypertensive 3-(ureidocyclohexyleneamino)propane-1,2-diol derivatives
JP2003055344A (ja) ３，７−ジ置換インドール誘導体及びそれを含有する医薬組成物
EP0168181B1 (en) Cyclic amides
NO158940B (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme indolderivater.
NO149775B (no) Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning
KR830001667B1 (ko) 페닐 퀴놀리지딘의 제조방법
US4278798A (en) 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and esters thereof
US4374261A (en) 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxo-nicotinic acid and esters thereof
JP2005531545A (ja) 塩酸ベナゼプリルの調製方法
US4314063A (en) 1-Ethyl-1,4,5,6-tetrahydro-6-(2-naphthyl)-4-oxo-nicotinic acid and lower alkyl esters thereof